Virus-like particle (VLP)-based vaccines have been in the market since decades for preventing viral infection and have proven their usefulness also in other areas of biotechnology. Here, we describe in detail simple small-scale production and purification procedures for the generation of hepatitis B surface antigen (HBsAg) VLPs using Pichia pastoris as expression host. This protocol may also be applicable with variations to other HBsAg-based VLPs additionally carrying antigens of other pathogens
The surface antigen of hepatitis B virus (HBsAg) spontaneously aggregates into ‘empty’ virus-like pa...
This study describes the comparative expression and purification of hepatitis B surface antigen (HBs...
A study of the Mut+ phenotype for the expression of recombinant hepatitis B surface antigen (HBsAg) ...
Following earlier studies on high-level intracellular production of hepatitis B surface antigen (HBs...
Following earlier studies on high-level intracellular production of hepatitis B surface antigen (HBs...
The recombinant Hepatitis B surface Antigen (HBsAg) vaccine provides excellent protection against He...
A protective immune response against Hepatitis B infection can be obtained through the administratio...
Abstract Background Hepatitis B is a serious global public health concern. Though a safe and efficac...
Biotecnologia Aplicada 2000; Vol. 17 No. 1, pp. 52 Large-scale Production of recombinant Hepatitis B...
ABSTRACT: BACKGROUND: Hepatitis B is a serious global public health concern. Though a safe and effic...
BACKGROUND: Chimeric virus-like particles (VLP) allow the display of foreign antigens on their surfa...
The extraordinary immunogenicity of the envelope protein of Hepatitis B virus (HBsAg) has been explo...
Hepatitis B virus (HBV) infection is a worldwide health problem, which can lead to severe liver dise...
High-level expression and efficient assembly of Hepatitis B surface Antigen (HBsAg) particles have b...
Abstract Background A protective immune response against Hepatitis B infection can be obtained throu...
The surface antigen of hepatitis B virus (HBsAg) spontaneously aggregates into ‘empty’ virus-like pa...
This study describes the comparative expression and purification of hepatitis B surface antigen (HBs...
A study of the Mut+ phenotype for the expression of recombinant hepatitis B surface antigen (HBsAg) ...
Following earlier studies on high-level intracellular production of hepatitis B surface antigen (HBs...
Following earlier studies on high-level intracellular production of hepatitis B surface antigen (HBs...
The recombinant Hepatitis B surface Antigen (HBsAg) vaccine provides excellent protection against He...
A protective immune response against Hepatitis B infection can be obtained through the administratio...
Abstract Background Hepatitis B is a serious global public health concern. Though a safe and efficac...
Biotecnologia Aplicada 2000; Vol. 17 No. 1, pp. 52 Large-scale Production of recombinant Hepatitis B...
ABSTRACT: BACKGROUND: Hepatitis B is a serious global public health concern. Though a safe and effic...
BACKGROUND: Chimeric virus-like particles (VLP) allow the display of foreign antigens on their surfa...
The extraordinary immunogenicity of the envelope protein of Hepatitis B virus (HBsAg) has been explo...
Hepatitis B virus (HBV) infection is a worldwide health problem, which can lead to severe liver dise...
High-level expression and efficient assembly of Hepatitis B surface Antigen (HBsAg) particles have b...
Abstract Background A protective immune response against Hepatitis B infection can be obtained throu...
The surface antigen of hepatitis B virus (HBsAg) spontaneously aggregates into ‘empty’ virus-like pa...
This study describes the comparative expression and purification of hepatitis B surface antigen (HBs...
A study of the Mut+ phenotype for the expression of recombinant hepatitis B surface antigen (HBsAg) ...